ArticleJournal of translational medicine2026
IKBIP as a prognostic biomarker and immunotherapeutic target regulates the JAK-STAT3 signaling pathway to promote cervical cancer.
Yan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.